RBM3 and neoplasm: The possible mechanism proposed by the authors is that RBM3 in cancers involves in enhancing the balance between CD44v and CD44s expression to attenuate the stem cell like features to adapt to the change in the microenvironment for survival and repopulation of tumor cells.